
- 积分
- 80
- 威望
- 80
- 包包
- 167
|
回复 蒲公英 的帖子! X& U/ ^, \6 O( F: r
. P3 a# b: ?. e参考文献:+ u: ~- ]2 h* J( g! K
1 Krampera M, Glennie S, Dyaon J,et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood, 2003;101:3722-3729
8 o @" x+ E1 G0 ?' u" ~1 y* t2 Potian JA, Aviv H, Ponzio NM, et al. Vetolike activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol, 2003;171:3426-3434* K9 a" @* P- Y% @
3 Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci, 2005;12:47-57
' d- d3 V% B. M
7 y; s; ], O+ |& r4 DiNicola M, CarloStella C, Magni M, et al. Human bone marrow stromal cells suppress Tlymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002;99:3838-3843' P5 ]7 d- S& u
, n; l6 Y! B1 C/ n2 y, ~! e
5 Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitrogens and alloantigens by different mechanisms. Exp Cell Res, 2005; 305:33-41
& G( B8 t7 P9 T x# F& ^9 T! D
. [1 Z' _, T& Z T5 r& V/ p6 Sun S,Guo Z,Xiao X,et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cell, 2003;21:527-535
' ]8 E* n4 E7 v+ E. {7 v! Q4 P2 R" e" Z" H0 d4 R
7 Maccario R, Podesta M, Moretta A, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigenspecific immune response favors the differentiation of CD4 Tcell subsets expressing a regulatory/suppressive phenotype. Haematologica, 2005;90:516-525
0 y6 {+ ^) k( O3 ^
. k, @. L. l/ t3 S2 u& J- B* H8 Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003;102: 3837-38445 i6 [- { T( x6 b' P
. k( c* j$ v, w: h8 m9 Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell response. Blood, 2005; 105:1815-18229 S" j. ]) H# y& f- ]
, J# a# U1 |% E2 O) D2 C# w10 Beyth S, Borovsk Z, Mevorach D,et al. Human mesenchymal stem cells alter antigen presenting cell maturation and induce Tcell unresponsiveness. Blood, 2005; 105:2214-2219
) v! S9 V6 R$ f$ u9 a/ _1 [8 q! y8 x
11 Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocytederived dentritic cells. Blood, 2005; 105; 4120-4126( W2 D+ E1 U" o# C/ B3 x/ L
2 @+ ~/ X/ L% _7 W. k9 Z5 z7 ?2 H
12 Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34 derived and monocytederived dendritic cells. J Immunol, 2006; 177: 2080-2087: G! U$ H- ]5 Z
( {$ c, `, _) k3 }+ p13 Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 2003; 76 :1208-1213
& f% w8 c4 A3 Q. X) ^
% s* o6 a! w7 x0 K14 Angoulvant D, Clerc A, Benchalal S, et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology, 2004; 41:469-476
, N4 m m9 b M
2 ~1 o, x- r) v1 Q0 G8 I' \8 J15 Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002; 30: 42-48
# {5 ~' R, Z2 f; j
# d) N" @* K( _" r$ s0 i: I- r l8 J16 Guo Z, Li H, Li X, et al. In vitro characteristics and in vivo immunosuppressive activity of compact bonederived murine mesenchymal progenitor cells. Stem Cells,2006; 24: 992-1000" G- }) m; X: `* ?) a; l
% ~3 O- D6 M' t1 e' j& P: S; ]2 ~
17 Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood, 2005; 106: 1755-1761
; ] f* [. B4 P. d4 s5 X# m' q; {) ~, }1 M: p; j& ~# d
18 Lazarus HM, Haynesworth SE, Gerson SL, et al. Ex vivo expansion and subsequent infusion of human bone marrowderived stromal progenitor cells (mesenchymal stem cells): implication for therapeutic use. Bone Marrow Transplant, 1995; 16: 557-564 f* N' a2 U$ ^. H/ A% ^) Z+ J6 E
5 M; [* O# F5 @; \$ p7 x0 e% {/ t1 ]19 Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLAidentical sibling cultureexpanded mesenchymal stem cells and hematopioetic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005; 11:389-398- A" @) x; p2 a8 G+ p. r
) y% w) L% W5 |20 Lee ST, Jang JH, Cheong JW, et al. Treatment of highrisk acute myelogenous leukemia by myeloablative chemoradiotherapy followed by coinfusion of T celldepleted haematopioetic stem cells and cultureexpanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol, 2002; 118:1128-1131
. b5 J- z2 k$ c" Q* m. X1 z$ v3 `" E% Y9 r+ ~
21 LeBlanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graftversushost disease with third party haploidentical mesenchymal stem cells. Lancet, 2004; 363(9419):1439-1411; a% c/ I- Y; X. m7 E' t
|
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|